Strides announces relaunch of ranitidine tablets for the US Market
Product to be relaunched with immediate effect
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Suresh Prabhu inaugurates 3rd International Leadership Summit Authentication Forum in Delhi
Incident of counterfeit cases in India have increased by nearly 15 per cent in 2019. Currency, Liquor, FMCG (F&B) and pharma…
36th Global GS1 Healthcare Conference held in Delhi
Organised for the first time in India, the event witnessed and welcomed regulatory bodies, international organisations and more…
Quality by Design (QbD) and its implementation in Pharma Industry
Ranjit Barshikar, QbD/cGMP consultant; Quality Expert - Consulting at United Nations MPP projects and member of Editorial Board of…
Lupin posts net loss of Rs 123 crore in Q2
The company had posted net profit of Rs 288.45 crore in July-September period of 2018-19
Judge shields OxyContin-maker Purdue from litigation until April
This gives time to the maker of OxyContin time to try to reach legal settlement the company says is worth $10 billion
Preparing Pharma For the Future: How Learning Management Systems are Bridging the Skill Gap
Kamal Dutta, MD India for Skillsoft writes about the perks of investing in up-skilling and retraining programmes for employees by…
Stada buys Takeda drug bundle to boost Russia business
The portfolio, which Takeda is selling in a push to slash debt after its $59 billion purchase of Shire, includes drugs sold…
CPhI Worldwide announces the winners of the 16th Pharma Awards
Dr Ge Li wins ‘CEO of the year’ and John Chiminski a ‘lifetime achievement award’, with 11 further outstanding winners unveiled
Ajanta Pharma Q2 net profit dips 7 to Rs 116 crore
Income from operations rose to Rs 643 crore during the period under review, as compared with Rs 544 crore in the year-ago period